MongoDB shares received price-target hikes from several analysts, on the database platform's fiscal-second-quarter results that surpassed expectations.
For the quarter ended July 31, MongoDB incurred a loss of -24 cents a share, compared with -39 cents a share loss expected by analysts polled by FactSet.
Revenue rose +44% from the year-ago quarter to $198.7 million, beating analysts' expectations of $182.4 million.
Oppenheimer analyst Ittai Kidron boosted the price target to $470 from $400. Kidron affirmed his outperform rating on the company’s shares. According to Kidron, MongoDB had a "strong" July quarter, with revenue and loss per share beating estimates on the back of robust subscription revenue growth and an "impressive" performance from Atlas. He noted that Atlas is increasingly becoming MongoDB's primary growth engine. Looking forward, the analyst expects continued investment in C-level engagement to bolster long-term expansion.
Barclays analyst Raimo Lenschow hiked his price target on MongoDB shares to $505 from $420, while maintaining his overweight rating on the shares. Lenschow said that investor focus for the second quarter was on the performance of Atlas, and the results "did not disappoint." Atlas has a run rate above $400 million. He said the performance would lead to analysts revising their estimates upward. Lenschow indicated that based on MongoDB's continued product enhancements and sales motion evolution, he is sanguine that the company "has a long growth runway ahead."
Canaccord analyst David Hynes raised his price target on MongoDB shares to $290 from $245, while keeping a buy rating on the shares. According to Hynes, the stock is expensive but the company has one of the largest still growing total addressable markets. The analyst said that favorable secular trends will boost both new and expansion opportunities.
MDB saw its Momentum Indicator move above the 0 level on April 22, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 74 similar instances where the indicator turned positive. In of the 74 cases, the stock moved higher in the following days. The odds of a move higher are at .
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MDB's RSI Oscillator exited the oversold zone, of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for MDB just turned positive on April 10, 2025. Looking at past instances where MDB's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MDB advanced for three days, in of 321 cases, the price rose further within the following month. The odds of a continued upward trend are .
MDB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MDB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for MDB entered a downward trend on April 16, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (24.272) is normal, around the industry mean (30.917). P/E Ratio (0.000) is within average values for comparable stocks, (160.020). Projected Growth (PEG Ratio) (1.654) is also within normal values, averaging (2.714). Dividend Yield (0.000) settles around the average of (0.029) among similar stocks. P/S Ratio (15.083) is also within normal values, averaging (59.831).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. MDB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MDB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a developer of MongoDB database
Industry PackagedSoftware